248 related articles for article (PubMed ID: 33750100)
1. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
[TBL] [Abstract][Full Text] [Related]
2. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
6. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
8. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy.
Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q
Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152
[TBL] [Abstract][Full Text] [Related]
9. A dual gate-controlled intelligent nanoreactor enables collaborative precise treatment for cancer nanotherapy.
Zhang H; Tang W; Gong Q; Yang X; Sun Y; Dai Z; Hu Z; Zheng X
Nanoscale; 2022 Sep; 14(36):13113-13122. PubMed ID: 36052962
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
[TBL] [Abstract][Full Text] [Related]
11. Buffet-style Cu(II) for enhance disulfiram-based cancer therapy.
Zhao L; Wang X; Lou H; Jiang M; Wu X; Qin J; Zhang J; Guan X; Li W; Zhang W; Ma J
J Colloid Interface Sci; 2022 Oct; 624():734-746. PubMed ID: 35696791
[TBL] [Abstract][Full Text] [Related]
12. In situ generation of copper(Ⅱ)/diethyldithiocarbamate complex through tannic acid/copper(Ⅱ) network coated hollow mesoporous silica for enhanced cancer chemodynamic therapy.
Zhu Y; Wang N; Ling J; Yang L; Omer AM; Ouyang XK; Yang G
J Colloid Interface Sci; 2024 Apr; 660():637-646. PubMed ID: 38266345
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer.
Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S
Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
15. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
[TBL] [Abstract][Full Text] [Related]
16. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
17.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
18. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
19. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy.
Qu Y; Li A; Ma L; Iqbal S; Sun X; Ma W; Li C; Zheng D; Xu Z; Zhao Z; Ma D
Int J Pharm; 2021 Mar; 597():120250. PubMed ID: 33486040
[TBL] [Abstract][Full Text] [Related]
20. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
